Findings highlight use of once-weekly injection to expand potential options for weight reduction, A1C control, knee osteoarthritis, and obstructive sleep apneaNEW ORLEANS, June 6,...
Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s
CHICAGO, June 22, 2025 /PRNewswire/ -- A recent study found that oral semaglutide offers meaningful cardiovascular benefits...
Common obesity drug reduced the risk of disease progression by 54%
CHICAGO, June 21, 2025 /PRNewswire/ -- Today, a new analysis demonstrates the vascular...
Hybrid closed-loop technology effectively helped women stay in target glucose range for longer compared to standard of care
CHICAGO, June 20, 2025 /PRNewswire/ -- A...